Detalhe da pesquisa
1.
Enfortumab Vedotin and Pembrolizumab in Untreated Advanced Urothelial Cancer.
N Engl J Med
; 390(10): 875-888, 2024 Mar 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38446675
2.
Nivolumab plus Gemcitabine-Cisplatin in Advanced Urothelial Carcinoma.
N Engl J Med
; 389(19): 1778-1789, 2023 Nov 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37870949
3.
Perioperative Pembrolizumab for Early-Stage Non-Small-Cell Lung Cancer.
N Engl J Med
; 389(6): 491-503, 2023 Aug 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37272513
4.
A nationwide phase II study of delayed local treatment for children with high-risk neuroblastoma: The Japan Children's Cancer Group Neuroblastoma Committee Trial JN-H-11.
Pediatr Blood Cancer
; 71(6): e30976, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38577760
5.
Magnesium supplementation therapy to prevent cisplatin-induced acute nephrotoxicity in pediatric cancer: a randomized phase-2 trial.
Int J Clin Oncol
; 29(5): 629-637, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38564107
6.
Effectiveness and safety of primary prophylaxis of granulocyte colony-stimulating factor during dose-dense chemotherapy for urothelial cancer: Clinical Practice Guidelines for the Use of G-CSF 2022.
Int J Clin Oncol
; 29(5): 545-550, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38517658
7.
Sarcopenia is associated with leukopenia in urothelial carcinoma patients who receive tislelizumab combined with gemcitabine and cisplatin therapy.
Int J Clin Oncol
; 29(5): 592-601, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38514497
8.
Activation of the hypothalamic-pituitary-adrenal axis by exogenous and endogenous GDF15.
Proc Natl Acad Sci U S A
; 118(27)2021 07 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34187898
9.
[A Case of Stage â £ Gastric Cancer with Multiple Liver Metastases, Resected Primary Tumor after Chemotherapy, and Alive for 3.5 Years without Recurrence].
Gan To Kagaku Ryoho
; 51(4): 433-435, 2024 Apr.
Artigo
em Japonês
| MEDLINE | ID: mdl-38644313
10.
Avelumab Maintenance Therapy for Advanced or Metastatic Urothelial Carcinoma.
N Engl J Med
; 383(13): 1218-1230, 2020 09 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-32945632
11.
Atezolizumab for First-Line Treatment of PD-L1-Selected Patients with NSCLC.
N Engl J Med
; 383(14): 1328-1339, 2020 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32997907
12.
A randomized phase 3 trial of autologous vs allogeneic transplantation as part of first-line therapy in poor-risk peripheral T-NHL.
Blood
; 137(19): 2646-2656, 2021 05 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-33512419
13.
Genetic variations in ABC transporter genes as a predictive biomarker for toxicity in North Indian lung cancer patients undergoing platinum-based doublet chemotherapy.
J Biochem Mol Toxicol
; 37(3): e23269, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-36507589
14.
NUT Carcinoma in Children and Adolescents: The Expert European Standard Clinical Practice Harmonized Recommendations.
J Pediatr Hematol Oncol
; 45(4): 165-173, 2023 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36219702
15.
REV1 inhibitor JH-RE-06 enhances tumor cell response to chemotherapy by triggering senescence hallmarks.
Proc Natl Acad Sci U S A
; 117(46): 28918-28921, 2020 11 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-33168727
16.
Kidney-Targeted Renalase Agonist Prevents Cisplatin-Induced Chronic Kidney Disease by Inhibiting Regulated Necrosis and Inflammation.
J Am Soc Nephrol
; 33(2): 342-356, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34921111
17.
Toripalimab Plus Chemotherapy for Recurrent or Metastatic Nasopharyngeal Carcinoma: The JUPITER-02 Randomized Clinical Trial.
JAMA
; 330(20): 1961-1970, 2023 11 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-38015220
18.
Senolytic-Mediated Elimination of Head and Neck Tumor Cells Induced Into Senescence by Cisplatin.
Mol Pharmacol
; 101(3): 168-180, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34907000
19.
Early nucleolar responses differentiate mechanisms of cell death induced by oxaliplatin and cisplatin.
J Biol Chem
; 296: 100633, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33819479
20.
Evaluation of an EZH2 inhibitor in patient-derived orthotopic xenograft models of pediatric brain tumors alone and in combination with chemo- and radiation therapies.
Lab Invest
; 102(2): 185-193, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34802040